<back

Bio/Medical Technology Club of Houston Meeting Announcement

Meeting Topic:
“Envisioning the Future of Platelet Therapy - ThromboVision”

Speaker:
Edward R. Teitel, MD, JD, MBA
President & CEO
ThromboVision, Inc.

Dr. Teitel served as Senior Vice President and Chief Medical Officer at MicroMed Technology, Inc. (now MicroMed Cardiovascular, Inc., a public company) until leaving to help found and lead ThromboVision, Inc. As a part of senior management at MicroMed, Dr. Teitel participated in all aspects of clinical trials and regulatory matters, business scope and fund raising activities, as well as legal matters. As chief medical officer for the DeBakey Left Ventricular Assist Device at MicroMed, Dr. Teitel acquired extensive experience in platelet function and anti-platelet therapy, especially relating to artificial surface devices. This background allowed Dr. Teitel to recognize the life saving and market potential of the T-Guide technology.

Before joining MicroMed Technology in 2002, Dr. Teitel practiced for many years as a board certified general and vascular surgeon. He founded, managed, and developed a multi-specialty group practice in Alabama until he closed his practice in 1997 to transition into corporate medicine and management. At that time he went on to earn his MBA at Auburn University and worked with a boutique investment banking firm, Colby Capital, in Atlanta where he worked to fund start-up companies in the life sciences. After completing law school in 2002, he joined the senior management team at MicroMed.

Dr. Teitel earned his MD degree at the University of Texas Health Science Center at San Antonio, and completed his surgical residency at St. Mercy Medical Hospital in Pontiac, Michigan. He received his Juris Doctor degree from the University of Houston, with a focus in healthcare law, intellectual property and business law. Dr. Teitel holds a BS in chemistry from Sul Ross State University.

The Company:  ThromboVision, Inc.

For years, cardiovascular patients have been taking anti-platelet medications to prevent life-threatening adverse cardiovascular events such as heart attacks, strokes and stent occlusions—without knowing whether their therapies were effective. ThromboVision has developed a new medical device – the ThromboVision ThromboGuideTM (T-GuideTM) platelet therapy monitoring system.  This device provides a simple, inexpensive solution to help physicians and their patients monitor and assess anti-platelet therapies.  The T-Guide measures platelet aggregation using a patented light scattering technology which identifies and monitors the function of platelets and how they are affected by anti-platelet drugs such as aspirin (ASA) and clopidogrel (Plavix®). www.thrombovision.com

Date/Time:
Tuesday, November 7, 2006
7:00 am - 8:30 am

New Location:
Trevisio Restaurant (Water Wall Building in the Texas Medical Center)
6th Floor
6550 Bertner Ave (Off Holcombe Blvd, East of Fannin)
Houston, TX 77030
(713) 749-0400

Map: www.bmtchouston.org/meetings/location.asp

Pricing: Includes Breakfast Hospitality and Parking
$15 - Members with online reservations
$20 - Members with no reservations or non-members with online reservations
$25 - Non-members with no reservations

Reservations:
Online reservation requires all members AND non-members to setup an account on the BMTC web site.

Registration Closed

Payments by cash or check prior to the event are to be mailed to:
BMTC
P.O. Box 66488
Houston, TX 77266-6488

January 2006 forward, pre-registration payments by credit card are non-refundable with no-shows billed.

Day of Event Registration:
On site registrations are welcome the day of the event. Payment on site is by
cash or check only. Correct change is appreciated.

Thank you and we look forward to seeing you at this event.

Bio/Medical Technology Club of Houston
www.bmtchouston.org

 

[return to top]